000 | 01644 a2200433 4500 | ||
---|---|---|---|
005 | 20250516123056.0 | ||
264 | 0 | _c20130328 | |
008 | 201303s 0 0 eng d | ||
022 | _a1521-0103 | ||
024 | 7 |
_a10.1124/jpet.112.200444 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJiang, Jianxiong | |
245 | 0 | 0 |
_aRole of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cFeb 2013 |
||
300 |
_a360-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Movement _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCinnamates _xpharmacology |
650 | 0 | 4 |
_aCytokines _xbiosynthesis |
650 | 0 | 4 | _aFluorescence Resonance Energy Transfer |
650 | 0 | 4 |
_aGlioma _ximmunology |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProstatic Neoplasms _ximmunology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReceptors, Prostaglandin E, EP2 Subtype _xantagonists & inhibitors |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aTransfection |
700 | 1 | _aDingledine, Ray | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 344 _gno. 2 _gp. 360-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.112.200444 _zAvailable from publisher's website |
999 |
_c22301324 _d22301324 |